BRAF V600E MUTATIONS IN METASTATIC MELANOMA - CASE REPORT

The treatment of metastatic melanoma represents a challenge. Vemurafenib, a selective BRAF kinase inhibitor, is a new medicine against carcinoma. Recently, it has been shown that it raises the survival rate among patients with metastatic melanoma who have BRAFV600mutation. This work will discuss new...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Ivana Inić, Momcilo Inić, Zorka Inić, Milan Zegarac, Aleksandar Martinović, Miomir Šašić, Miloš Bracanović, Gordana Pupić
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: University in Nis, Faculty of Medicine 2014-09-01
श्रृंखला:Acta Medica Medianae
विषय:
metastatic melanoma
BRAF V600 mutation
treatment
ऑनलाइन पहुंच:http://publisher.medfak.ni.ac.rs/2014-html/3-broj/Ivana%20Inic-BRAF.pdf
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन